Mark Jerome Pykett is a businessperson who founded Cytomatrix and who has been the head of 7 different companies.
He is Chairman of Inflectis Bioscience SAS. Dr. Pykett is also on the board of Pharming Group NV and Exubrion Therapeutics, Inc.
In his past career Dr. Pykett occupied the position of Chief Executive Officer & Director at Navidea Biopharmaceuticals, Inc., President & Chief Operating Officer at Alseres Pharmaceuticals, Inc., President of Cordlife Group Ltd. and President & Chief Executive Officer for Cytomatrix (a subsidiary of Cordlife Group Ltd.), Chief Scientific Officer for PTC Therapeutics, Inc. and President, Chief Executive Officer & Director at Agilis Biotherapeutics LLC (a subsidiary of PTC Therapeutics, Inc.) and President at CyGenics Ltd.
He received a doctorate from the University of Pennsylvania, an undergraduate degree from Amherst College, an MBA from Northeastern University and a doctorate from the University of Pennsylvania School of Veterinary Medicine.